<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03515876</url>
  </required_header>
  <id_info>
    <org_study_id>2018-52</org_study_id>
    <nct_id>NCT03515876</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine on Segmental EEG Power Spectra</brief_title>
  <official_title>The Effects of Dexmedetomidine on Segmental EEG Power Spectra Activity Under Propofol-based Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhiyi Zuo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the EEG power spectra activity during propofol-based anesthesia in the presence or
      absence of dexmedetomidine in patients undergoing hysteroscopic examination and surgery to
      determine whether the addition of dexmedetomidine will induce better sleep-like anesthesia
      status.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Three groups of patients undergoing hysteroscopic examination and surgery will be studied: 1)
      control group, patients will receive propofol intravenous infusion to provide anesthesia; 2)
      dexmedetomidine 0.5 microgram/kg group. This dexmedetomidine dose is infused within 10 min
      and then the use of propofol for anesthesia; and 3) dexmedetomidine 1 microgram/kg group.
      This dexmedetomidine dose is infused within 10 min and then the use of propofol for
      anesthesia.

      Each group will have 20 patients.

      General conditions including blood pressure, respiration, and heart rates will be recorded.

      EEG power spectra activity will be recorded no-invasively by a Narcotrend EEG monitor.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2018</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>EEG power spectra</measure>
    <time_frame>From prior to anesthesia to 10 min after anesthesia.</time_frame>
    <description>EEG power spectra monitored no-invasively by Narcotrend</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>From prior to anesthesia to 10 min after anesthesia.</time_frame>
    <description>Blood pressure monitored no-invasively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiration</measure>
    <time_frame>From prior to anesthesia to 10 min after anesthesia.</time_frame>
    <description>Monitored no-invasively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rates</measure>
    <time_frame>From prior to anesthesia to 10 min after anesthesia.</time_frame>
    <description>Monitored no-invasively</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia</condition>
  <condition>EEG Power Spectra</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients will receive intravenous propofol infusion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine 0.5 microgram/kg group</arm_group_label>
    <description>Patients will receive dexmedetomidine 0.5 microgram/kg and then intravenous propofol infusion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine 1 microgram/kg group</arm_group_label>
    <description>Patients will receive dexmedetomidine 1 microgram/kg and then intravenous propofol infusion.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients for hysteroscopic examination and surgery under general anesthesia.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists Physical status I to II grade.

          -  body mass index 18 to 25 kg/m2

          -  no vision or hearing impairment

          -  will receive general anesthesia

        Exclusion Criteria:

          -  with psychological or mental diseases

          -  with neurological diseases

          -  treating with steroids or with alcohol dependence.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Patients undergoing hysteroscopic examination and surgery.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhi Wang, MD</last_name>
    <phone>13622740039</phone>
    <email>wwzz1898@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sun Yat-Sen Memorial Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wang Zhi, MD, Ph.D.</last_name>
      <phone>13622740039</phone>
      <email>wwzz1898@163.com</email>
    </contact>
    <investigator>
      <last_name>Zhi Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2018</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Zhiyi Zuo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

